Bafna Pharmaceuticals, a Chennai-based Pharma company, has doubled the sales of Raricap over the previous year. The company had acquired legacy Brand Raricap two years ago. Raricap is the only brand available in the market with a unique iron salt Ferrous Calcium Citrate (FCC). Ferrous Calcium Citrate a complex salt benefits the patients by enhancing dietary iron absorption unlike other conventional salts.
Sales of Raricap during FY 2012-13 were Rs 16.15 crore against Rs 7.78 crore in FY 2011- 12. Moreover, the sales of Raricap in April 2013 were registered at Rs 2.18 crore. Within 2nd year of launch, Raricap has reached 22nd position as per AIOCD (Mar '13 MAT Value) in haematinic segment.
Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.25 |
Dr. Reddys Lab | 5794.30 |
Cipla | 1449.85 |
Zydus Lifesciences | 1027.90 |
Lupin | 1583.45 |
View more.. |